Target intelligence / Profile preview

Pathogen and autoantigen epitopes

Molecular classification
Other
01

Overview

Pathogen and autoantigen epitopes are the specific molecular regions of antigens that are recognized by the adaptive immune system, specifically by antibodies, B cells, or T cells (Janeway's Immunobiology, 9th ed.). Pathogen epitopes are derived from foreign invaders such as viruses, bacteria, and fungi, serving as the primary targets for protective immune responses and vaccine development (Nature Reviews Immunology, 2018, 18: 543–559). Autoantigen epitopes are derived from the host's own proteins and are the targets of aberrant immune attacks in autoimmune diseases, such as Type 1 Diabetes or Multiple Sclerosis (Frontiers in Immunology, 2020, 11: 590110). In therapeutic contexts, pathogen epitopes are utilized in vaccines to prime the immune system, while autoantigen epitopes are increasingly used in tolerogenic therapies to retrain the immune system to ignore self-tissues (Nucleic Acids Research, 2019, 47: D339–D343). Understanding the precise structure and binding affinity of these epitopes is crucial for the design of highly specific biologics and personalized immunotherapies.

Other names
Antigenic determinantsImmune epitopesB-cell epitopesT-cell epitopesSelf-epitopesForeign epitopes
02

Mechanism of action

Epitopes serve as the specific binding sites for immune receptors (BCRs, TCRs) and antibodies, facilitating the recognition and subsequent immune response or tolerance induction.

03

Biological functions

Immune responseImmune toleranceAntigen presentation
04

Disease associations

InfectionAutoimmune diseaseAllergyCancer
05

Safety considerations

Molecular mimicry leading to autoimmunityOff-target cross-reactivityImmune evasion through epitope mutationAnaphylactic reactions
06

Interacting drugs

Vaccines

3 more in the full profile.

07

Biomarkers

Epitope-specific antibody titersT-cell ELISpot assaysMHC-peptide multimer staining

Beyond the preview

Go deeper on Pathogen and autoantigen epitopes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen and autoantigen epitopes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call